跳至主要内容
临床试验/NCT06195813
NCT06195813已完成2 期

Effects of Asparagus Capsule Consumption on Blood Sugar and Lipids and Oxidative Stress in Overweight and Obese Participants

Burapha University2 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2022年12月20日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
44
试验地点
2
主要终点
Level of body fat

研究概览

简要总结

Participants were 44 overweight and obese persons, male and female, age 18-59 years. Participants were divided into 2 groups consisting of 23 asparagus capsules and 21 placebo capsules groups. They received health screenings including history taking, mental health questionnaire, and vital signs, height and body weight, body composition, fat distribution measurements and oral glucose tolerance test. Then, a venipuncture was conducted to determine blood glucose, insulin, lipids malondialdehyde and protein carbonyl levels.

详细描述

The study design was cross-sectional. Participants were 44 overweight and obese persons, male and female, age 18-59 years. Participants were divided into 2 groups consisting of 23 asparagus capsules and 21 placebo capsules groups. They received health screenings including history taking, mental health questionnaire, and vital signs, height and body weight, body composition, fat distribution measurements and oral glucose tolerance test. Then, a venipuncture was conducted to determine blood glucose, insulin, lipids malondialdehyde and protein carbonyl levels. Analysis of covariance was used to analyze parameters between groups and paired t-test was used to analyze parameters intra-group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 59 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Man or woman, aged between 18 to 59 years
  • Body mass index more than 23 (Asian criteria)
  • No history of hypertension, diabetes, cardiovascular disease, respiratory disease, endocrine disease, neuromuscular disease, musculoskeletal disease, liver disease, renal disease, immune disease, infectious disease, or cancer
  • No regular intake of dietary supplements, i.e., vitamins, antioxidants
  • No regular smokers or alcohol drinkers (>2 times per week)
  • Not sportman or regular exerciser (>2 times per week or >150 min per week)
  • No food allergy, especially shoot

排除标准

  • Current signs or symptoms of infection, i.e., fever, hyperpnea, dyspnea, and palpitations.

结局指标

主要结局

Level of body fat

时间窗: Day 0 and end of 12 weeks

Level of body fat was measured in percentage unit

Level of fat mass

时间窗: Day 0 and end of 12 weeks

Level of fat mass was measured in kilogram unit

Level of fat distribution

时间窗: Day 0 and end of 12 weeks

Level of fat distribution was measured by ratio of waist (centimeter) to hip (centimeter)

Concentration of blood glucose

时间窗: Day 0 and end of 12 weeks

Concentration of blood glucose was measured in serum in mmol/L unit

Concentration of blood insulin

时间窗: Day 0 and end of 12 weeks

Concentration of blood insulin was measured in serum in uU/mL (microunit/milliliter) unit

Concentration of blood malondialdehyde

时间窗: Day 0 and end of 12 weeks

Concentration of blood malondialdehyde was measured in plasma in uM (micromolar) unit

Concentrations of blood lipids

时间窗: Day 0 and end of 12 weeks

Concentrations of total cholesterol, triglyceride, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol were measured in serum in mg/dL unit

Concentration of blood protein carbonyl

时间窗: Day 0 and end of 12 weeks

Concentration of blood protein carbonyl was measured in plasma in nmol/mg protein unit

次要结局

  • Concentrations of blood glucose from oral glucose tolerance test(At 0 minute before glucose consumption and at 30, 60, 90, 120 minutes after glucose consumption)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Piyapong Prasertsri

Associate Professor Dr.

Burapha University

研究点 (2)

Loading locations...

相似试验